DUBLIN–(BUSINESS WIRE)–The “Biodefence Market Report 2023-2033” report has been added to ResearchAndMarkets.com’s offering.
This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Increasing R&D Investments in Developed Countries
Growing R&D investments enable pharmaceutical and biopharmaceutical companies to manufacture superior quality and technologically advanced bio-threat detection devices that should significantly impact the industry growth.
Furthermore, European government also supports the R&D activities to manufacture vaccines against various diseases such as anthrax, small pox and botulism in large batches to fight infections and prevent the spread of endemic diseases.
Bioterrorism attacks lead to deaths and may weaken the economy hence, government funds various pharmaceutical as well as biopharmaceutical companies that will elevate the industry growth in foreseeable future.
Increasing Awareness Regarding Bioterrorism Attacks to Propel Industry Growth
Increasing awareness regarding bioterrorism attacks in developed as well as underdeveloped economies will significantly fuel the biodefence market growth over the forecast period. Owing to the advent of internet and growing adoption of social media, news about the biological warfare in any part of the world can spread across the globe. It can cause anxiety to people located faraway and can greatly impact trade and travel.
Governments in the developing countries such as Japan and India plan public awareness campaigns to raise public awareness about bioterrorism attacks. Such preventive measures undertaken by the government to combat various endemic diseases will boost industry growth in the foreseeable future.
Low Government Funding in Underdeveloped Regions Likely to Challenge Market Growth
Minimal government intervention and low R&D funding in underdeveloped regions will impede the biodefence market growth over the forecast period. Furthermore, due to poor economic development, governments and regulatory authorities in countries such as Mexico and Brazil are unable to make significant investments to promote the use of biothreat detection devices. There is a lack of awareness in developing regions about the availability of technologically advanced biothreat detection devices.
Additionally, there is no established regulatory framework for biodefence devices and vaccines in underdeveloped economies. Key players that operate in the biodefence industry find it difficult to enter these countries due to changing trade policies. As a result, the distribution of tools and vaccinations used to combat bioterrorism is low in emerging regions which may hamper the Biodefence market growth.
What Questions Should You Ask before Buying a Market Research Report?
- How is the Biodefence Market evolving?
- What is driving and restraining the Biodefence Market?
- How will each Biodefence submarket grow over the forecast period and how much revenue will these submarkets account for in 2033?
- How will the market shares for each Biodefence submarket develop from 2023 to 2033?
- What will be the main driver for the overall market from 2023 to 2033?
- Will leading Biodefence Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
- Who are the leading players and what are their prospects over the forecast period?
- What are the Biodefence development projects for these leading companies?
- How will the industry evolve during the period between 2023 and 2033? What are the implications of Biodefence development projects taking place now and over the next 10 years?
- Is there a greater need for product commercialization to further scale the Biodefence Market?
- Where is the Biodefence Market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
Leading companies and the potential for market growth
- Alexeter Technologies, LLC,
- Altimmune
- Achaogen, Inc.
- Alnylam Pharmaceuticals
- ANP Technology
- Bavarian Nordic
- BBI Detection
- Biofire Defense (bioMerieux SA)
- Biosearch Technologies
- Bruker
- Dynport Vaccine Company
- Electronic Sensor Technology Inc.
- Elusys Therapeutics
- Emergent BioSolutions Inc.
- Ichor Medical
- NanoLogix
- New Horizons Diagnostic Corporation
- PositiveID Corporation
- Research International
- SIGA Technologies, Inc.
- Statera Biopharma (Cleveland Biolabs)
- Smith’s Detection
- Synexis Systems
Key Topics Covered:
1 Report Overview
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing R&D investments by the government
3.2.1.2 Favorable government initiatives in emerging economies
3.2.1.3 Technological developments in biotechnology sector in the developed countries
3.2.2 Market Restraining Factors
3.2.2.1 Low R&D funding in underdeveloped regions
3.2.3 Market Opportunities
3.2.3.1 Increasing list of bio-threat agents
3.2.3.2 Development of advanced biotechnology products
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.5 PEST Analysis
4 Biodefence Market Analysis by Product
5 Biodefence Market Analysis by Region
6 North America Biodefence Market Analysis
7 Europe Biodefence Market Analysis
8 Asia Pacific Biodefence Market Analysis
9 Latin America Biodefence Market Analysis
10 MEA Biodefence Market Analysis
11 Company Profiles
12 Conclusion and Recommendations
For more information about this report visit https://www.researchandmarkets.com/r/6c81y8
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900